This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Neurology  • Cerebrovascular Disease  • Stroke  • Cardiovascular System  • Pulmonary Diseases  • Chronic Obstructive Pulmonary Disease  • Statistics and Research Methods  • Cardiovascular Disease/ Myocardial Infarction  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The meta-analysis by Dr Singh and colleagues¹ appears to demonstrate an increased risk of cardiovascular death, myocardial infarction, or stroke events in patients using inhaled anticholinergics. I believe that this study incorporates errors in article identification and data extraction.

At least 1 article that meets the authors' search criteria for long-acting anticholinergics and recorded cardiovascular events was not included.² The event data in Casaburi et al³ showed no difference between tiotropium and controls (7 deaths in each group and serious adverse event rates of 18% in the tiotropium group vs 21% in the control group). However, Singh et al reported 12 vs 3 events, respectively. The study by Wedzicha et al⁴ apparently showed 36 events in the tiotropium group and 26 events in the control group when nervous system, vascular, and cardiac disorders were combined, whereas Singh et al reported 23 vs 13 events, respectively. Reanalysis of . . . [Full Text of this Article]

Henry D. Covelli, MD
hcovelli@roadrunner.com
Coeur d’Alene, Idaho

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis
Sonal Singh, Yoon K. Loke, and Curt D. Furberg
JAMA. 2008;300(12):1439-1450.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease
Yuji Oba
JAMA. 2009;301(12):1223.
EXTRACT | FULL TEXT  

Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease
Steven Kesten, Inge Leimer, and Michele Jara
JAMA. 2009;301(12):1224.
EXTRACT | FULL TEXT  

Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease
Katherine E. Hodgin and James P. Maloney
JAMA. 2009;301(12):1224.
EXTRACT | FULL TEXT  

Risk of Major Adverse Cardiovascular Events With Inhaled Anticholinergics in Patients With Chronic Obstructive Pulmonary Disease—Reply
Sonal Singh, Yoon K. Loke, and Curt D. Furberg
JAMA. 2009;301(12):1225-1226.
EXTRACT | FULL TEXT